5th Annual Controlled and Modified Drug Release Summit (Philadelphia, United States - November 28-29, 2018)

  • ID: 4462019
  • Conference
  • Location: Philadelphia, United States
  • 2 Days
  • Curtis & Coulter
  • Conference Dates: November 28-29, 2018
1 of 4
Innovative Controlled and Modified Drug Release Strategies That Will Benefit Your Current and Future Product Pipelines

This intensive 2-Day program will share innovative controlled and modified drug release strategies that will benefit your current and future product pipelines.

Learn directly from industry’s leading experts and hear unique case study sessions and take-home examples to enhance your product pipeline. Gather insights into the latest technologies and methods in improving drug release mechanisms, maximizing exposure, and reducing time-to-market. Additionally, this must-attend event will showcase the latest regulatory guidance updates and the implications for the industry.

Topics Include:

  • Localized & targeted delivery
  • Pediatric dosage forms & delivery
  • QBD Strategy
  • Novel alliance management strategies
  • Enhancing patient adherence for drug delivery
  • Evaluating innovations in oral drug formulation and delivery technologies
  • Implementing innovative strategies around drug / device combinations
  • Advances in ocular delivery
  • Parenteral routes of administration
  • Topical and Transdermal Delivery
  • Combining In-Vivo animal models with physiologically-based PBPK modeling
  • Modified release technologies for product lifecycle extensions

Benefits of Attending:

  • 70+ Industry-led Speakers
  • 200 Senior Participants
  • 10+ Networking Hours

Engage in dynamic conversation with your industry peers at our multiple networking sessions, and takeaway novel controlled and modified release strategies, which could speed up time to market and save your organization millions.

Note: Product cover images may vary from those shown
2 of 4


3 of 4

Esmaiel Jabbri, PhD.
Professor of Chemical Engineering, University of South Carolina

René Holm, PhD.
Head and Scientific Director, Liquids & Parenterals, The Janssen Pharmaceutical Companies of Johnson & Johnson

Nicholas Warne, PhD.
Senior Director, Formulation, Pfizer, Inc.

Note: Product cover images may vary from those shown
4 of 4

Pharmaceutical, biotech and academic professionals specializing in:

  • Drug Delivery
  • Pharmaceutics
  • PK-PD
  • Physiochemistry
  • Formulation / Pre-Formulation
  • Medicinal / Analytical / Solid state Chemistry
  • Preclinical / Analytical Development
  • Product Enhancement / Development
  • CMC
  • Regulatory Affairs
  • Drug Discovery
  • Life-Cycle / Portfolio Management
  • Partnering, Licensing & Alliance Management
  • Intellectual Property
  • Toxicology
  • Process R&D
Note: Product cover images may vary from those shown
5 of 4


Philadelphia Marriott Downtown
1201 Market St
PA 19107
United States

Note: Product cover images may vary from those shown